Palvella Therapeutics, Inc.

PVLA Nasdaq SEC CIK 1583648
Follow Palvella Therapeutics Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$24.6M −117.2% vs same quarter last year
EPS, diluted −$1.70 −65% vs same quarter last year
Operating cash flow −$14.4M −83.1% vs same quarter last year
Operating income −$22.7M −123.3% vs same quarter last year
Net income by quarter
−$4M
−$8.2M
−$9.5M
−$11.3M
−$12.7M
−$15.8M
−$21.9M
−$24.6M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income14 fiscal years
  • Revenue
  • Net income
−$50M−$25M$0$25M$50MFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25-−$41.7M
FY24-−$17.4M
FY23$42.8M$18.7M
FY22$25.9M−$33.3M
FY21$31.4M−$45.7M
FY20$29.3M−$37.2M
FY19$43.6M−$25.5M
FY18$27.2M−$26.8M
FY17$25.3M−$17.6M
FY16$5.8M−$22.8M
FY15$2.9M−$14.1M
FY14$5.4M−$9.8M
FY13$12.4M$66.2K
FY12--
MarginsShare of revenue
  • Operating margin
  • Net margin
−600%−400%−200%0%200%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearOperating marginNet margin
FY25--
FY24--
FY23−27.7%43.7%
FY22−167.8%−128.5%
FY21−165%−145.6%
FY20−115.7%−127%
FY19−62.2%−58.4%
FY18−113.1%−98.2%
FY17−57.7%−69.8%
FY16−390.3%−391%
FY15−466.6%−479.5%
FY14−134.2%−183.6%
FY134.5%0.5%
FY12--
Free cash flowOperating cash flow minus capital expenditure
−$100M−$50M$0$50MFY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25-
FY24-
FY23−$13.9M
FY22−$61M
FY21−$8.6M
FY20−$48.6M
FY19−$54.9M
FY18−$2.8M
FY17$47.8M
FY16−$14.9M
FY15−$13.3M
FY14−$282.5K
FY13−$3.1M
FY12-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Palvella Therapeutics
  • Healthcare median
−600%−400%−200%0%200%FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearPalvella TherapeuticsHealthcare median
FY25-−30.6%
FY24-−47%
FY2343.7%−58%
FY22−128.5%−80.4%
FY21−145.6%−71.9%
FY20−127%−62.2%
FY19−58.4%−46.3%
FY18−98.2%−49.6%
FY17−69.8%−45.9%
FY16−391%−36%
FY15−479.5%−38.4%
FY14−183.6%−35.5%
FY130.5%−37.1%
FY12-−29.1%